Esther van Twuijver - Concepedia

Author

Esther van Twuijver

HAL Allergy (Netherlands)ORCID

Also Known As

E. van Twuijver, Esther Van Twuijver, Esther van Twuijver, José Plácido, van Twuijver, E.

Publications

152

Citations

H-Index

Concepts

All Affiliations

HAL Allergy (Netherlands)Heidelberg University Zentrum für Rhinologie und Allergologie University Hospital Heidelberg University of Amsterdam

About

Esther van Twuijver is an author at HAL Allergy (Netherlands) specializing in immunology, food allergies, and toxicology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	27
2	Allergy	1	1	27
3	Allergy Medicine	1	1	27
4	Immunology	1	1	27
5	Food Allergies	1	1	27

Esther van Twuijver

Publications

130

Citations

H-Index

Page 1

	Year	Citations
A randomized <scp>DBPC</scp> trial to determine the optimal effective and safe dose of a <scp>SLIT</scp>‐birch pollen extract for the treatment of allergic rhinitis: results of a phase <scp>II</scp> study Oliver Pfaar, Esther van Twuijver, J. D. Boot, Allergy	2015	46
Accelerated Up-Dosing of Subcutaneous Immunotherapy with a Registered Allergoid Grass Pollen Preparation Oliver Pfaar, Esther van Twuijver, Heike Hecker, International Archives of Allergy and Immunology	2012	27
SCIT-treatment With a Chemically Modified, Aluminum Hydroxide Adsorbed Peanut Extract (HAL-MPE1) Was Generally Safe And Well Tolerated And Showed Immunological Changes In Peanut Allergic Patients Carsten Bindslev‐Jensen, Pieter‐Jan de Kam, Esther van Twuijver, Journal of Allergy and Clinical Immunology Food AllergyAllergyAllergy MedicineImmunologyPeanut Allergy	2017	27
A prospective study comparing the efficacy and safety of two sublingual birch allergen preparations Ludger Klimek, Annette Sperl, Esther van Twuijver, Clinical and Translational Allergy	2014	10
Antibody responses against heterologous A/H5N1 strains for an MF59-adjuvanted cell culture–derived A/H5N1 (aH5N1c) influenza vaccine in healthy pediatric subjects Pornthep Chanthavanich, Eve Versage, Esther van Twuijver, Vaccine	2021	10
Antibody responses against heterologous H5N1 strains for an MF59-adjuvanted cell culture–derived H5N1 (aH5n1c) influenza vaccine in adults and older adults Sharon S. Frey, Eve Versage, Esther van Twuijver, Human Vaccines & Immunotherapeutics	2023	10

Page 1